Eris Lifesciences Ltd
NSE:ERIS
Eris Lifesciences Ltd
NSE:ERIS
Price:
1 348
INR
0.42%
Market Closed
Market Cap:
₹186.7B
Balance Sheet
Balance Sheet Decomposition
Eris Lifesciences Ltd
Eris Lifesciences Ltd
Balance Sheet Decomposition is not available for
Eris Lifesciences Ltd
Eris Lifesciences Ltd
Balance Sheet
Eris Lifesciences Ltd
Eris Lifesciences Ltd
Currency: INR
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
28
|
20
|
66
|
50
|
89
|
23
|
106
|
75
|
673
|
369
|
509
|
560
|
942
|
1 997
|
|
| Cash |
28
|
20
|
66
|
50
|
89
|
23
|
106
|
75
|
673
|
369
|
509
|
560
|
942
|
1 997
|
|
| Short-Term Investments |
200
|
494
|
676
|
700
|
645
|
902
|
938
|
3 149
|
748
|
504
|
995
|
300
|
12 446
|
57
|
|
| Total Receivables |
236
|
310
|
355
|
298
|
349
|
640
|
1 135
|
1 412
|
2 108
|
2 189
|
2 713
|
4 593
|
5 712
|
5 825
|
|
| Accounts Receivables |
144
|
166
|
223
|
237
|
254
|
489
|
666
|
840
|
1 569
|
1 345
|
1 580
|
2 880
|
4 221
|
4 586
|
|
| Other Receivables |
92
|
144
|
132
|
61
|
95
|
151
|
469
|
572
|
539
|
844
|
1 133
|
1 714
|
1 491
|
1 238
|
|
| Inventory |
226
|
432
|
448
|
576
|
493
|
583
|
771
|
1 112
|
1 207
|
1 513
|
1 798
|
1 995
|
3 026
|
3 896
|
|
| Other Current Assets |
4
|
8
|
9
|
11
|
18
|
12
|
37
|
70
|
60
|
96
|
259
|
199
|
895
|
455
|
|
| Total Current Assets |
693
|
1 264
|
1 555
|
1 635
|
1 593
|
2 160
|
2 987
|
5 818
|
4 796
|
4 670
|
6 273
|
7 647
|
23 020
|
12 230
|
|
| PP&E Net |
198
|
235
|
711
|
675
|
707
|
558
|
526
|
561
|
873
|
779
|
1 919
|
3 774
|
5 583
|
7 288
|
|
| PP&E Gross |
198
|
235
|
711
|
675
|
0
|
558
|
526
|
561
|
873
|
779
|
1 919
|
3 774
|
5 583
|
7 288
|
|
| Accumulated Depreciation |
89
|
118
|
163
|
315
|
0
|
208
|
390
|
544
|
577
|
978
|
750
|
934
|
1 450
|
2 213
|
|
| Intangible Assets |
1
|
1
|
7
|
7
|
7
|
1 382
|
6 250
|
6 136
|
6 985
|
6 841
|
6 596
|
18 806
|
29 134
|
37 327
|
|
| Goodwill |
33
|
33
|
32
|
36
|
0
|
378
|
935
|
936
|
935
|
935
|
935
|
3 318
|
8 672
|
9 120
|
|
| Note Receivable |
34
|
91
|
111
|
92
|
149
|
159
|
181
|
154
|
123
|
539
|
71
|
55
|
657
|
727
|
|
| Long-Term Investments |
0
|
0
|
170
|
973
|
1 544
|
2 131
|
2 716
|
409
|
32
|
2 436
|
4 208
|
69
|
157
|
622
|
|
| Other Long-Term Assets |
61
|
95
|
121
|
156
|
187
|
499
|
1 006
|
1 523
|
1 780
|
2 148
|
2 720
|
3 004
|
3 182
|
3 018
|
|
| Other Assets |
33
|
33
|
32
|
36
|
0
|
378
|
935
|
936
|
935
|
935
|
935
|
3 318
|
8 672
|
9 120
|
|
| Total Assets |
1 020
N/A
|
1 718
+68%
|
2 706
+58%
|
3 573
+32%
|
4 186
+17%
|
7 267
+74%
|
14 601
+101%
|
15 537
+6%
|
15 523
0%
|
18 348
+18%
|
22 721
+24%
|
36 673
+61%
|
70 405
+92%
|
70 332
0%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
181
|
220
|
374
|
367
|
246
|
385
|
908
|
841
|
1 001
|
1 026
|
1 178
|
1 248
|
2 189
|
3 324
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
597
|
1 492
|
|
| Short-Term Debt |
8
|
42
|
74
|
24
|
32
|
71
|
3
|
0
|
8
|
0
|
0
|
550
|
17 488
|
3 966
|
|
| Current Portion of Long-Term Debt |
24
|
20
|
5
|
5
|
5
|
2
|
1 026
|
1 761
|
120
|
23
|
40
|
1 383
|
3 409
|
2 996
|
|
| Other Current Liabilities |
140
|
153
|
259
|
259
|
407
|
300
|
318
|
452
|
518
|
620
|
779
|
1 224
|
1 638
|
2 036
|
|
| Total Current Liabilities |
353
|
436
|
713
|
655
|
690
|
758
|
2 255
|
3 055
|
1 647
|
1 669
|
1 996
|
4 432
|
25 321
|
13 814
|
|
| Long-Term Debt |
26
|
6
|
0
|
5
|
0
|
5
|
2 742
|
3
|
61
|
44
|
804
|
6 834
|
6 915
|
17 817
|
|
| Deferred Income Tax |
1
|
0
|
0
|
0
|
0
|
347
|
523
|
517
|
506
|
495
|
461
|
2 576
|
5 344
|
5 185
|
|
| Minority Interest |
50
|
47
|
44
|
39
|
32
|
238
|
247
|
183
|
0
|
0
|
1
|
247
|
6 359
|
4 174
|
|
| Other Liabilities |
111
|
169
|
181
|
213
|
256
|
248
|
222
|
273
|
345
|
374
|
378
|
624
|
604
|
799
|
|
| Total Liabilities |
541
N/A
|
657
+21%
|
937
+43%
|
912
-3%
|
977
+7%
|
1 595
+63%
|
5 988
+275%
|
4 031
-33%
|
2 560
-36%
|
2 584
+1%
|
3 638
+41%
|
14 713
+304%
|
44 543
+203%
|
41 788
-6%
|
|
| Equity | |||||||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
138
|
138
|
138
|
136
|
136
|
136
|
136
|
136
|
136
|
|
| Retained Earnings |
478
|
1 060
|
1 767
|
2 659
|
3 207
|
5 534
|
8 476
|
11 354
|
12 828
|
15 628
|
18 841
|
21 673
|
25 545
|
28 114
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
0
|
0
|
106
|
151
|
181
|
293
|
|
| Total Equity |
479
N/A
|
1 061
+122%
|
1 769
+67%
|
2 660
+50%
|
3 208
+21%
|
5 671
+77%
|
8 613
+52%
|
11 505
+34%
|
12 963
+13%
|
15 764
+22%
|
19 083
+21%
|
21 960
+15%
|
25 862
+18%
|
28 544
+10%
|
|
| Total Liabilities & Equity |
1 020
N/A
|
1 718
+68%
|
2 706
+58%
|
3 573
+32%
|
4 186
+17%
|
7 267
+74%
|
14 601
+101%
|
15 537
+6%
|
15 523
0%
|
18 348
+18%
|
22 721
+24%
|
36 673
+61%
|
70 405
+92%
|
70 332
0%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
138
|
138
|
138
|
138
|
138
|
138
|
138
|
138
|
136
|
136
|
136
|
136
|
136
|
136
|
|
Switch to:
Switch to:
See Also
Discover More
